Hsin‐Pai Li

1.2k total citations
29 papers, 943 citations indexed

About

Hsin‐Pai Li is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hsin‐Pai Li has authored 29 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Hsin‐Pai Li's work include Viral-associated cancers and disorders (6 papers), RNA Research and Splicing (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). Hsin‐Pai Li is often cited by papers focused on Viral-associated cancers and disorders (6 papers), RNA Research and Splicing (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). Hsin‐Pai Li collaborates with scholars based in Taiwan, United States and Germany. Hsin‐Pai Li's co-authors include Yu‐Sun Chang, Kai‐Ping Chang, Roger Duncan, Lucio Comai, Xuming Zhang, Michael M. C. Lai, Michael M. C. Lai, Chuen Hsueh, Lih‐Chyang Chen and I‐Che Chung and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Oncogene and Journal of Virology.

In The Last Decade

Hsin‐Pai Li

29 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsin‐Pai Li Taiwan 15 409 295 189 177 156 29 943
Wei Jia China 18 459 1.1× 126 0.4× 84 0.4× 276 1.6× 132 0.8× 58 893
Hidemi Toyoda Japan 18 325 0.8× 157 0.5× 191 1.0× 80 0.5× 264 1.7× 63 956
Nancy MacKay United Kingdom 18 453 1.1× 184 0.6× 98 0.5× 60 0.3× 125 0.8× 49 908
Roger Mountford United Kingdom 15 323 0.8× 473 1.6× 138 0.7× 120 0.7× 42 0.3× 22 1.3k
Cristiana Iosef United States 21 358 0.9× 112 0.4× 267 1.4× 179 1.0× 248 1.6× 34 1.2k
Toshihiko Ishii Japan 21 461 1.1× 371 1.3× 108 0.6× 61 0.3× 769 4.9× 41 1.5k
Lisa Welter United States 9 165 0.4× 230 0.8× 139 0.7× 162 0.9× 173 1.1× 16 642
Beata Majchrzak-Kita Canada 20 417 1.0× 397 1.3× 340 1.8× 54 0.3× 600 3.8× 32 1.2k
Sumita Bhaduri‐McIntosh United States 21 488 1.2× 625 2.1× 171 0.9× 139 0.8× 384 2.5× 51 1.2k
Ronald Jubin United States 15 718 1.8× 229 0.8× 127 0.7× 42 0.2× 295 1.9× 26 1.4k

Countries citing papers authored by Hsin‐Pai Li

Since Specialization
Citations

This map shows the geographic impact of Hsin‐Pai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsin‐Pai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsin‐Pai Li more than expected).

Fields of papers citing papers by Hsin‐Pai Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsin‐Pai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsin‐Pai Li. The network helps show where Hsin‐Pai Li may publish in the future.

Co-authorship network of co-authors of Hsin‐Pai Li

This figure shows the co-authorship network connecting the top 25 collaborators of Hsin‐Pai Li. A scholar is included among the top collaborators of Hsin‐Pai Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsin‐Pai Li. Hsin‐Pai Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Cheng–Lung, Yu‐Sun Chang, & Hsin‐Pai Li. (2024). Molecular diagnosis of nasopharyngeal carcinoma: Past and future. Biomedical Journal. 48(1). 100748–100748. 14 indexed citations
2.
Li, Hsin‐Pai, Chen‐Yang Huang, Kar‐Wai Lui, et al.. (2023). Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways. Translational Oncology. 38. 101785–101785. 3 indexed citations
3.
Li, Hsin‐Pai, Chen‐Yang Huang, Kar‐Wai Lui, et al.. (2021). Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment. Cancers. 13(12). 2954–2954. 11 indexed citations
4.
Lin, Chiao‐Yun, Ren‐Chin Wu, Chen‐Yang Huang, et al.. (2021). A Patient-Derived Xenograft Model of Dedifferentiated Endometrial Carcinoma: A Proof-of-Concept Study for the Identification of New Molecularly Informed Treatment Approaches. Cancers. 13(23). 5962–5962. 7 indexed citations
5.
Wu, Chi‐Sheng, Ian Yi‐Feng Chang, Wei‐Chao Liao, et al.. (2020). ASC modulates HIF-1α stability and induces cell mobility in OSCC. Cell Death and Disease. 11(9). 721–721. 9 indexed citations
6.
OuYang, Chun‐Nan, Hsuan Liu, Mei Chao, et al.. (2019). Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathway. Cancer Medicine. 8(11). 5116–5127. 13 indexed citations
7.
Chung, I‐Che, Chun‐Nan OuYang, Hsin‐Pai Li, et al.. (2016). Pyk2 activates the NLRP3 inflammasome by directly phosphorylating ASC and contributes to inflammasome-dependent peritonitis. Scientific Reports. 6(1). 36214–36214. 71 indexed citations
8.
Lee, Chi‐Ching, Po-Jung Huang, Hsin‐Pai Li, et al.. (2015). RNA recombination in Hepatitis delta virus: Identification of a novel naturally occurring recombinant. Journal of Microbiology Immunology and Infection. 50(6). 771–780. 17 indexed citations
9.
Li, Hsin‐Pai, et al.. (2014). Silencing of miRNA-148a by hypermethylation activates the integrin-mediated signaling pathway in nasopharyngeal carcinoma. Oncotarget. 5(17). 7610–7624. 39 indexed citations
10.
Li, Hsin‐Pai, I‐Che Chung, Meiyuan Huang, et al.. (2013). Aberrantly hypermethylated Homeobox A2 derepresses metalloproteinase-9 through TBP and promotes invasion in Nasopharyngeal carcinoma. Oncotarget. 4(11). 2154–2165. 26 indexed citations
11.
Hsu, Cheng‐Lung, Kai‐Ping Chang, Chien‐Yu Lin, et al.. (2011). Plasma epstein‐barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma. Head & Neck. 34(8). 1064–1070. 54 indexed citations
12.
Lu, Yen‐Jung, Chi‐Sheng Wu, Hsin‐Pai Li, et al.. (2010). Aberrant methylation impairs low density lipoprotein receptor‐related protein 1B tumor suppressor function in gastric cancer. Genes Chromosomes and Cancer. 49(5). 412–424. 47 indexed citations
13.
Tse, Ka‐Po, Hsin‐Pai Li, Ying Liang, et al.. (2007). MCP-1 Promoter Polymorphism at −2518 Is Associated with Metastasis of Nasopharyngeal Carcinoma after Treatment. Clinical Cancer Research. 13(21). 6320–6326. 50 indexed citations
14.
Chen, Li‐Kuang, et al.. (2005). Thermal aggregation of SARS-CoV membrane protein. Journal of Virological Methods. 129(2). 152–161. 53 indexed citations
15.
Li, Hsin‐Pai & Yu‐Sun Chang. (2003). Epstein-Barr Virus Latent Membrane Protein 1: Structure and Functions. Journal of Biomedical Science. 10(5). 490–504. 9 indexed citations
16.
Li, Hsin‐Pai & Yu‐Sun Chang. (2003). Epstein-barr virus latent membrane protein 1: Structure and functions. Journal of Biomedical Science. 10(5). 490–504. 149 indexed citations
17.
Yu, Jau‐Song, Hsing-Chen Tsai, Chih‐Ching Wu, et al.. (2002). Induction of inducible nitric oxide synthase by Epstein-Barr virus B95-8-derived LMP1 in Balb/3T3 cells promotes stress-induced cell death and impairs LMP1-mediated transformation. Oncogene. 21(52). 8047–8061. 20 indexed citations
18.
Shi, Stephanie T., et al.. (2001). Regulation of Mouse Hepatitis Virus RNA synthesis by Heterogeneous Nuclear Ribonucleoprotein Al. Advances in experimental medicine and biology. 494. 429–436. 1 indexed citations
19.
20.
Zhang, Xuming, et al.. (1998). Cellular Protein hnRNP-A1 Interacts with the 3’-end and the Intergenic Sequence of Mouse Hepatitis Virus Negative-Strand RNA to Form a Ribonucleoprotein Complex. Advances in experimental medicine and biology. 440. 227–234. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei Jia Breakdown of academic impact, for papers by Hidemi Toyoda Breakdown of academic impact, for papers by Nancy MacKay Breakdown of academic impact, for papers by Roger Mountford Breakdown of academic impact, for papers by Cristiana Iosef Breakdown of academic impact, for papers by Toshihiko Ishii Breakdown of academic impact, for papers by Lisa Welter Breakdown of academic impact, for papers by Beata Majchrzak-Kita Breakdown of academic impact, for papers by Sumita Bhaduri‐McIntosh Breakdown of academic impact, for papers by Ronald Jubin
Rankless by CCL
2026